Daesang Corporation (KRX:001680)
South Korea · Delayed Price · Currency is KRW 23,150
-450 (-1.91%)
Last updated: Feb 26, 2026, 10:49 AM KST
Daesang Revenue
Daesang had revenue of 1.15T KRW in the quarter ending September 30, 2025, with 3.02% growth. This brings the company's revenue in the last twelve months to 4.40T, up 4.65% year-over-year. In the year 2024, Daesang had annual revenue of 4.26T with 3.59% growth.
Revenue (ttm)
4.40T
Revenue Growth
+4.65%
P/S Ratio
0.19
Revenue / Employee
870.59M
Employees
5,050
Market Cap
842.00B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.26T | 147.64B | 3.59% |
| Dec 31, 2023 | 4.11T | 23.40B | 0.57% |
| Dec 31, 2022 | 4.08T | 614.10B | 17.70% |
| Dec 31, 2021 | 3.47T | 356.79B | 11.46% |
| Dec 31, 2020 | 3.11T | 149.22B | 5.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Harim Holdings | 13.23T |
| Daesang Holdings | 5.62T |
| Otoki | 3.67T |
| SPC Samlip | 3.40T |
| EASY HOLDINGS | 3.39T |
| Pulmuone Corporate | 3.34T |
| Samyang | 2.60T |
| Kwang Dong Pharmaceutical | 1.64T |